2025-07-05 - Analysis Report
Okay, here's the analysis of Hims & Hers Health Inc (HIMS) based on the provided data, presented in an English report format with numerical highlights and subsequent analysis:

**Hims & Hers Health Inc (HIMS) Stock Analysis**

**Ticker:** HIMS
**Company Description:** Hims & Hers Health Inc is a telehealth company that offers personalized health and wellness solutions directly to consumers.

**1. Performance Relative to S&P 500 (VOO)**

*   **HIMS Cumulative Return:** 181.27%
*   **VOO (S&P 500) Cumulative Return:** 64.73%
*   **Absolute Divergence (Current):** 193.7
*   **Relative Divergence (Percentile):** 74.8%

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) based on cumulative returns. The current divergence is 193.7. A relative divergence of 74.8% indicates that HIMS's outperformance is in the upper range of its historical divergence from the S&P 500.

*   **Alpha, Beta Analysis**

| Year       | CAGR    | MDD    | Alpha   | Beta   | Cap(B) |
|------------|---------|--------|---------|--------|--------|
| 2019-2021  | -46.0%  | 51.0%  | -84.0%  | -0.0   | 1.5    |
| 2020-2022  | -15.0%  | 72.1%  | -17.0%  | -0.0   | 1.4    |
| 2021-2023  | -51.0%  | 72.1%  | -69.0%  | -0.1   | 2.0    |
| 2022-2024  | 127.0% | 78.4% | 101.0% | -0.1   | 5.4    |
| 2023-2025  | 176.0% | 78.4% | 128.0% | -0.1   | 10.7   |

**Analysis:**
*   **CAGR & MDD:** The CAGR (Compound Annual Growth Rate) shows high volatility, with significant losses in some periods (e.g., -51% in 2021-2023) and substantial gains in others (e.g., 176% in 2023-2025).  MDD (Maximum Drawdown) is consistently high, indicating significant potential for loss.
*   **Alpha:** Alpha values are predominantly negative in earlier periods, suggesting underperformance relative to the benchmark. However, the recent periods (2022-2024 and 2023-2025) show very high positive alpha, indicating significant outperformance.
*   **Beta:** Beta values are consistently close to zero.

**2. Recent Stock Price Movement**

*   **Current Price:** $47.98
*   **Previous Close:** $47.46
*   **Change:** 1.1%
*   **5-Day Moving Average:** 48.47
*   **20-Day Moving Average:** 52.54
*   **60-Day Moving Average:** 46.69

**Analysis:** The stock price has increased by 1.1% compared to the previous close, indicating a positive movement. The current price is below the 5-day and 20-day moving averages but above the 60-day moving average. This suggests a possible short-term downward trend but a longer-term upward trend.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 40.48
*   **PPO:** -1.82
*   **Hybrid Signal:** Cash_69%_Sell 1.6% of holdings (22 shares - Caution - MRI:0.33)
*   **Recent Change in Relative Divergence (20-day):** -0.7 (Negative - Short-term Decline)
*   **Expected Return:** -9.3% (Long-term, relative to S&P 500)

**Analysis:** The MRI indicates a low-risk environment. The RSI of 40.48 suggests that the stock is not overbought or oversold. The negative PPO indicates a potential downward trend in price momentum. The hybrid signal suggests a cautious approach, recommending a high cash position (69%) and selling a small portion of holdings. The negative recent change in relative divergence further indicates a short-term downward trend. The expected return of -9.3% suggests that long-term investments in HIMS may underperform the S&P 500. The change of 1.1% indicates a small positive movement

**4. Recent News & Significant Events**

*   **2025-07-02:** Major business developments, regulatory changes, or market events are affecting HIMS.
*   **2025-07-05:** Analysts are discussing HIMS's recent performance in the context of industry trends and global economic factors.
*   **2025-07-04:** HIMS's stock has shown notable volatility due to recent news, earnings reports, or executive actions.
*   **2025-07-01:** Market experts highlight both risks and opportunities for HIMS.

**Analysis:** Recent news suggests that HIMS is experiencing significant developments and volatility. Investors should closely monitor news and company announcements to make informed decisions.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue  |
|------------|------|----------|
| 2025-05-05 | 0.22 | $0.59B  |
| 2024-11-04 | 0.35 | $0.40B  |
| 2024-08-05 | 0.06 | $0.32B  |
| 2024-05-06 | 0.05 | $0.28B  |
| 2025-05-05 | 0.05 | $0.28B  |

**Analysis:** The latest earnings data (2025-05-05) shows EPS at 0.22 and revenue at $0.59B. Overall, there appears to be a positive trend in both EPS and revenue over the quarters, although the EPS is fluctuating.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $0.59B    | 73.50%        |
| 2024-12-31   | $0.48B    | 76.81%        |
| 2024-09-30   | $0.40B    | 79.16%        |
| 2024-06-30   | $0.32B    | 81.30%        |
| 2024-03-31   | $0.28B    | 82.36%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-03-31   | $0.55B    | 9.01% |
| 2024-12-31   | $0.48B    | 5.46% |
| 2024-09-30   | $0.44B    | 17.18% |
| 2024-06-30   | $0.36B    | 3.67% |
| 2024-03-31   | $0.34B    | 3.23% |

**Analysis:** Revenue is increasing, but Profit Margin has decreased. Equity is also increasing, and ROE (Return on Equity) has fluctuated over the quarters.

**7. Overall Analysis**

Hims & Hers Health Inc (HIMS) has significantly outperformed the S&P 500, but it has also shown high volatility. Recent news suggests that the company is undergoing significant developments, which could impact its future performance. While revenue is increasing, profit margins have recently decreased. Technical indicators present a mixed picture, with the MRI indicating low risk but the hybrid signal suggesting caution.

**Recommendations:**

*   Given the recent negative trend in divergence and expected return, investors should exercise caution.
*   Monitor company announcements and news closely to assess the impact of recent developments on the company's performance.
*   Consider the high volatility and potential for significant losses before making investment decisions.
*   The hybrid signal's suggestion to maintain a high cash position and reduce holdings might be a prudent strategy given the uncertainty.
